
Story of 2021: The War on Treatment That Killed Millions | Guest: Dr. Tess Lawrie | 12/17/21
Conservative Review with Daniel Horowitz
00:00
Ivormectin - I'm Going to Follow Up With a Big Study
Oxford University has withdrawn from a trial of ivor mectin. The drug is used to treat high blood pressure in the U.S. It's unclear why they're pulling out, but it could be due to supply issues. Dr Andrew Keen says he feels sorry for oxford and their decision-making process.
Play episode from 39:23
Transcript


